BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21768869)

  • 1. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature.
    Obeid KM; Venugopal AA
    Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?
    Dasanu CA; Bockorny B
    J Oncol Pharm Pract; 2015 Oct; 21(5):377-9. PubMed ID: 24769519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rash diagnosis: Gemcitabine-associated pseudocellulitis.
    Strouse C; Epperla N
    J Oncol Pharm Pract; 2017 Mar; 23(2):157-160. PubMed ID: 26946530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
    Curtis S; Hong S; Gucalp R; Calvo M
    Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine associated pseudocellulitis.
    Singh A; Hampole H
    J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
    Bami H; Goodman C; Boldt G; Vincent M
    Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
    Tan DH; Bunce PE; Liles WC; Gold WL
    Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure: A Systematic Review.
    Kovacs LD; O'Donoghue M; Cogen AL
    JAMA Dermatol; 2023 Aug; 159(8):870-874. PubMed ID: 37379014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent lower extremity pseudocellulitis.
    Korniyenko A; Lozada J; Ranade A; Sandhu G
    Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-induced pseudocellulitis.
    Caplan A; Chu DH; Rosenbach M; Svoboda J
    Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of gemcitabine-related acute lipodermatosclerosis.
    Nyckowski T; McGregor S; Huang WW
    J Oncol Pharm Pract; 2019 Jul; 25(5):1271-1274. PubMed ID: 30041585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
    Li J; Ko CJ; Saif MW
    Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine associated pseudocellulitis: A missed diagnosis.
    Gill D; Schrader J; Kelly M; Martinez F; Syed W; Wright J
    J Oncol Pharm Pract; 2018 Oct; 24(7):550-552. PubMed ID: 28714381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-induced chronic systemic capillary leak syndrome.
    Bajwa R; Starr J; Daily K
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
    Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
    J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
    Shitara K; Ishiguro A; Munakata M; Sakata Y; Hirata N; Yabu K; Wada R
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1981-4. PubMed ID: 16282740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine-induced severe peripheral edema in a patient with lung cancer.
    Katsenos S; Nikolopoulou M
    J Pharm Pract; 2012 Jun; 25(3):393-5. PubMed ID: 22674969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
    Biswas S; Nik S; Corrie PG
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-related radiation recall in a patient with pancreatic cancer.
    Saif MW; Sellers S; Russo S
    Anticancer Drugs; 2006 Jan; 17(1):107-11. PubMed ID: 16317298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.
    Geffen DB; Horowitz J
    Isr Med Assoc J; 2000 Jul; 2(7):552-3. PubMed ID: 10979335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.